Examination of Trends in Non-Small Cell Lung Cancer Patients' Medical Study Experiences
Not yet recruiting
- Conditions
- Non-Small Cell Lung Cancer
- Registration Number
- NCT05778045
- Lead Sponsor
- Power Life Sciences Inc.
- Brief Summary
Medical study participation percentages haven't always been fully representative of a given demographic.
The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through.
Participating in an observational clinical trial may help patients with non-small cell lung cancer since it advances medical knowledge and may improve treatment choices in the future.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
- Participant has a diagnosis of non-small cell lung cancer
- Patient has self-identified as planning to enroll in a clinical trial for non-small cell lung cancer
- Patient is at least 18 years of age
Exclusion Criteria
- Inability to perform regular electronic reporting
- Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial
- Pregnant or lactating woman
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of patients who decide to enroll in a non-small cell lung cancer clinical study. 3 months Number of non-small cell lung cancer patients who remain in clinical trial until completion. 12 months
- Secondary Outcome Measures
Name Time Method